English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
None-----
Press release submission
| Apr 21, 2022
Zambon Receives U.S. FDA Breakthrough Therapy Designation for CMS I-neb® in Patients with Non-Cystic Fibrosis Bronchiectasis (NCFB)
Press release submission
| Apr 18, 2022
Alabama Patients Have Increased Access to Affordable, Quality Anesthesia Care
Trending
Patient Daily
| Oct 23, 2025
Dallas Breathe Free ENT Specialist: Humidity 'tends to help' with sinus issues
Patient Daily
| Oct 23, 2025
Capitol Breathe Free Otolaryngologist: ‘Allergy exacerbations are a common trigger for sinus infections'
+
Pharmaceuticals
Patient Daily
| Oct 23, 2025
Empower seeks dismissal of Eli Lilly suit in Texas federal court
+
Pharmaceuticals
Patient Daily
| Oct 29, 2025
Paragon Health Institute senior fellow: 340B program 'needs real reform'
